(*) USA Approval Year: 2017
(*) USA Launch: 2nd Quarter 2018
>Primary Hyperlipidemia>
Company
Generic Name: PitavaStatin Tablets
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2019. 10.22.
TradeMark
TradeMark Web-Site